Despite the disparity in serum leptin levels in IBD patients, low serum leptin levels are associated with increased IBD risk, suggesting the involvement of leptin-mediated pathways in the pathogenesis and progression of the disease [15,16,17]. This evidence concerns the gene LEP and inflammatory bowel disease.